Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roivant Social Ventures is a health-equity-focused nonprofit founded within the Roivant ecosystem that invests in, incubates, and supports early-stage health technologies and therapeutic programs aimed at underserved populations. The organization operates as a 501(c)(3) public charity and positions itself as a new model of corporate philanthropy, combining charitable capital with Roivant Sciences' operating infrastructure and expertise. Its work spans impact investing, startup incubation, global access initiatives for advanced therapies such as gene therapy, and educational programs to broaden diversity in biopharma leadership and clinical research. Rather than functioning as a traditional single-asset drug developer, RSV acts as a mission-driven healthcare venture and incubation platform designed to improve access, equity, and delivery in medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roivant Social Ventures.